Tumor antigens and vaccines in colorectal cancer
Colorectal cancer (CRC) is a common cancer in the world and also has a high death rate. It is reported that vaccination is a great strategy for CRC. CRC vaccines are based on CRC tumor antigens, including tumor-associated antigens like CEA, MUC-1, CTAs and tumor-specific antigens including personali...
Saved in:
Main Authors: | Zhongen Wu (Author), Mengxuan Yang (Author), Yiou Cao (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Inhibition of BCL9 Modulates the Cellular Landscape of Tumor-Associated Macrophages in the Tumor Immune Microenvironment of Colorectal Cancer
by: Zhuang Wei, et al.
Published: (2021) -
Preclinical support for tumor protein D52 as a cancer vaccine antigen
by: Robert K. Bright
Published: (2023) -
Assessment of serum carcinoembryonic antigen in colorectal cancer patients treated by surgery and chemotherapy
by: Shahbaa A. Al-Bayati
Published: (2011) -
Self-Tumor Antigens in Solid Tumors Turned into Vaccines by α-gal Micelle Immunotherapy
by: Uri Galili
Published: (2024) -
Enhanced tumor suppression in colorectal cancer via berberine-loaded PEG-PLGA nanoparticles
by: Fei Shen, et al.
Published: (2024)